Literature DB >> 25477578

Modafinil: Parkinson disease-related somnolence.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

Entities:  

Year:  2014        PMID: 25477578      PMCID: PMC4252229          DOI: 10.1310/hpj4907-612

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  13 in total

1.  Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil.

Authors:  Anette V Nieves; Anthony E Lang
Journal:  Clin Neuropharmacol       Date:  2002 Mar-Apr       Impact factor: 1.592

2.  Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.

Authors:  B Högl; M Saletu; E Brandauer; S Glatzl; B Frauscher; K Seppi; H Ulmer; G Wenning; W Poewe
Journal:  Sleep       Date:  2002-12       Impact factor: 5.849

Review 3.  Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

Authors:  J J Ferreira; R Katzenschlager; B R Bloem; U Bonuccelli; D Burn; G Deuschl; E Dietrichs; G Fabbrini; A Friedman; P Kanovsky; V Kostic; A Nieuwboer; P Odin; W Poewe; O Rascol; C Sampaio; M Schüpbach; E Tolosa; C Trenkwalder; A Schapira; A Berardelli; W H Oertel
Journal:  Eur J Neurol       Date:  2013-01       Impact factor: 6.089

4.  Canadian Guidelines on Parkinson's Disease.

Authors:  David Grimes; Joyce Gordon; Barbara Snelgrove; Ivy Lim-Carter; Edward Fon; Wayne Martin; Marguerite Wieler; Oksana Suchowersky; Alex Rajput; Anne L Lafontaine; Jon Stoessl; Elena Moro; Kerrie Schoffer; Janis Miyasaki; Doug Hobson; Minoo Mahmoudi; Susan Fox; Ron Postuma; Hrishikesh Kumar; Mandar Jog
Journal:  Can J Neurol Sci       Date:  2012-07       Impact factor: 2.104

5.  Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease.

Authors:  Charles H Adler; John N Caviness; Joseph G Hentz; Marlene Lind; Judy Tiede
Journal:  Mov Disord       Date:  2003-03       Impact factor: 10.338

6.  Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  T A Zesiewicz; K L Sullivan; I Arnulf; K R Chaudhuri; J C Morgan; G S Gronseth; J Miyasaki; D J Iverson; W J Weiner
Journal:  Neurology       Date:  2010-03-16       Impact factor: 9.910

7.  Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil.

Authors:  S Happe; W Pirker; C Sauter; G Klösch; J Zeitlhofer
Journal:  J Neurol       Date:  2001-07       Impact factor: 4.849

Review 8.  Excessive daytime sleepiness in patients with Parkinson's disease.

Authors:  Bettina Knie; M Tanya Mitra; Kartik Logishetty; K Ray Chaudhuri
Journal:  CNS Drugs       Date:  2011-03       Impact factor: 5.749

9.  Daytime sleepiness in elderly Parkinson's disease patients and treatment with the psychostimulant modafinil: A preliminary study.

Authors:  Johan Lökk
Journal:  Neuropsychiatr Dis Treat       Date:  2010-04-07       Impact factor: 2.570

10.  Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study.

Authors:  Jau-Shin Lou; Diana M Dimitrova; Byung S Park; Sarah C Johnson; Ryan Eaton; Grace Arnold; John G Nutt
Journal:  Clin Neuropharmacol       Date:  2009 Nov-Dec       Impact factor: 1.592

View more
  1 in total

Review 1.  The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice.

Authors:  Giuseppe Loddo; Giovanna Calandra-Buonaura; Luisa Sambati; Giulia Giannini; Annagrazia Cecere; Pietro Cortelli; Federica Provini
Journal:  Front Neurol       Date:  2017-02-16       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.